Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Serum NFL discriminates Parkinson Disease from Atypical Parkinsonisms
Neurol 92:e1479-e1486, Marques, T.M.,et al, 2019
Blood-based NfL - A biomarker for differential diagnosis of parkinsonian disorder
Neurol 88:930-937,922, Hansson, O.,et al, 2017